OTC · Medical - Devices

Vicarious Surgical Inc. (RBOT) Stock

$0.11 -4.39% OTC: RBOT Healthcare

Vicarious Surgical Inc. is dedicated to the development and commercialization of advanced single-incision surgical robotics.

Valuation

MetricValue
Price$0.11
Market Cap$712510
P/E Ratio-0.02
P/B Ratio0.21
P/S Ratio0.00
EPS (TTM)$-8.45
52-Week High$12.87
52-Week Low$0.10
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-333.19%
ROA-334.63%
ROCE-462.47%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity2.02
Current Ratio1.54

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-38.0M$-80.0M$-81.0M$-67.0M$-51.0M
Net Profit$-35.0M$5.0M$-71.0M$-63.0M$-50.0M
EPS$-10.92$1.21$-14.60$-10.72$-8.45
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$182.0M$140.0M$120.0M$68.0M$20.0M
Total Liabilities$99.0M$29.0M$22.0M$21.0M$10.0M
Cash$174.0M$116.0M$53.0M$10.0M$3.0M
Borrowings$1.0M$16.0M$15.0M$14.0M$8.0M

Latest News

Time runs out for Vicarious Surgical MedTech Dive · Jul 22, 2026 SS Innovations International (SSII) Appoints Sarah Romano as Chief Financial Officer NewMediaWire · Jul 15, 2026 Vicarious Surgical board proposes dissolving the company MedTech Dive · Jul 15, 2026 SS Innovations names Sarah Romano as CFO MedTech Dive · Jul 15, 2026 Vicarious Surgical Demonstrates Sustained System Performance and Complex Hernia Procedure Workflows in Pre-Clinical Setting GlobeNewswire · May 13, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-33.0M$-61.0M$-62.0M$-50.0M$-45.0M
Investing Cash Flow$-3.0M$-11.0M$-47.0M$7.0M$32.0M
Financing Cash Flow$191.0M$1.0M$-3.0M$0$0
Net Cash Flow$158.0M$-57.0M$-63.0M$-43.0M$-7.0M
Free Cash Flow$-35.0M$-67.0M$-64.0M$-50.0M$-45.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-0.16
FCF Yield-5569.69%
Quick Ratio1.54
Interest Coverage0.00
Return 1Y-99.17%
Return 3Y-99.82%
Return 5Y—

Ownership

Insiders Held14.84%
Institutions Held16.34%
Institutions Float Held19.19%
Institutional HolderSharesReport Date
Aspex Management (HK) Ltd86,6662026-03-31
Forum Finance Group S.a.3,3332026-03-31
Rockefeller Capital Management L.P.8842026-03-31
Daytona Street Capital LLC1002026-03-31
Federation Des Caisses Desjardins Du Quebec222026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About Vicarious Surgical Inc.

Vicarious Surgical Inc. is dedicated to the development and commercialization of advanced single-incision surgical robotics. Their innovative technology is designed to give surgeons a virtual, immersive presence within the patient's body, facilitating highly precise and minimally invasive operations. The company's primary product, the Vicarious System, is a sophisticated single-incision robot engineered specifically for procedures like ventral hernia repair. Established in 2014, Vicarious Surgical Inc. operates from its corporate headquarters in Waltham, Massachusetts.

Vicarious Surgical Inc. is headquartered in US.

Vicarious Surgical Inc. (RBOT) stock trades at $0.11 with a market capitalization of $712510. The stock is valued at a price-to-earnings (P/E) ratio of -0.02, price-to-book of 0.21, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.10 and $12.87, and currently trades 99.1% below its 52-week high.

On profitability, Vicarious Surgical Inc. generates a return on equity (ROE) of -333.19%, return on capital employed of -462.47%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: www.vicarioussurgical.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides